USPTO 2015–2025 USPTO PatentsView US Corporation

Beth Israel Deaconess Medical Center, Inc.

USPTO PatentsView assignee record - 261 granted patents across 50 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

261

Total patents granted

CPC technology areas

18.9

Avg claims per patent

-15%

5-year filing velocity

The verdict

Beth holds 261 US patents across 50 technology areas, rank #1,584 of 50,000 tracked assignees.

#1,584
of 50,000 US assignees by volume: Top 4%
by Innovation Score (59.5/100): 18.9
avg claims per patent: -15%
filing velocity, last 5 yrs

Portfolio overview

Beth Israel Deaconess Medical Center, Inc. has been granted 261 US utility patents between 2015 and 2025, placing Beth Israel Deaconess Medical Center, Inc. at rank #1,584 across all assignees tracked by PlainPatent. This portfolio spans 50 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.9 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a US Corporation, Beth Israel Deaconess Medical Center, Inc. is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Beth sits between Microjet Technology Co., Ltd. (262 patents, rank #1,580) and Brocade Communications Systems Llc (260 patents, rank #1,588) - the closest US assignees by grant volume. The composite Innovation Score of 59.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 120 grants, compared with 141 in the 2015–2019 window, a -15% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Beth Israel Deaconess Medical Center, Inc.'s 18.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 50 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Beth Israel Deaconess Medical Center, Inc. against peers pursuing similar technology classes.

Microjet Technolo…

262
National Universi…

262
The Lubrizol

262
Unisantis Singapo…

262
Ememory Technology

261
Kyushu University…

261
Sharp Laboratorie…

261
Beth Israel Deaco… ◀

261
Brocade Communica…

260

What this shows Beth holds 261 patents at rank #1,584, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Beth

By rank, the assignees closest to #1,584 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Beth's primary technology class.

Beth's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

60 Top 4% higher than 96% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Beth Israel Deaconess Medical Center, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	19	7.3%
2016	14	5.4%
2017	26	10.0%
2018	37	14.2%
2019	45	17.2%
2020	22	8.4%
2021	27	10.3%
2022	22	8.4%
2023	17	6.5%
2024	17	6.5%
2025	15	5.7%

Which technologies does Beth Israel Deaconess Medical Center, Inc. patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 157

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 117

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 81

C07K - PEPTIDES 78

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 55

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 48

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 35

C07D - HETEROCYCLIC COMPOUNDS 25

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 22

G01R - MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES 19

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 12

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 11

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 7

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 7

C09B - ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES ; , e.g. PIGMENTS; MORDANTS; LAKES 6

Top 15 of 50 technology areas

Patent Moat Analysis

Portfolio Volume Moderate

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#1,584

Across all tracked assignees

Innovation Score

59.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Beth Israel Deaconess Medical Center, Inc. hold?

Beth Israel Deaconess Medical Center, Inc. holds 261 US granted patents filed between 2015 and 2025, spanning 50 technology areas.

What is Beth Israel Deaconess Medical Center, Inc.'s Innovation Score?

Beth Israel Deaconess Medical Center, Inc. has an Innovation Score of 59.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Beth Israel Deaconess Medical Center, Inc. focus on?

Beth Israel Deaconess Medical Center, Inc.'s top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 157 patents. The company has filed patents in 50 CPC subclasses total.

Is Beth Israel Deaconess Medical Center, Inc.'s patent filing rate increasing or decreasing?

Beth Israel Deaconess Medical Center, Inc.'s recent filing velocity is -15% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Beth Israel Deaconess Medical Center, Inc.'s patents?

Beth Israel Deaconess Medical Center, Inc.'s patents average 18.9 claims each. This falls within the standard range, providing solid legal coverage.

How is the Beth Israel Deaconess Medical Center, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Beth's 261 grants land it in the top 4% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Beth ranks #1,584 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.